• Corpus ID: 37462203

Muscarinic actions of an N-methyl-N-2-bromoethylamino analog of oxotremorine (BR 401) in the mouse.

@article{Ringdahl1987MuscarinicAO,
  title={Muscarinic actions of an N-methyl-N-2-bromoethylamino analog of oxotremorine (BR 401) in the mouse.},
  author={Bj{\"o}rn Ringdahl and Donald J. Jenden},
  journal={The Journal of pharmacology and experimental therapeutics},
  year={1987},
  volume={240 2},
  pages={
          370-5
        }
}
  • B. Ringdahl, D. Jenden
  • Published 1 February 1987
  • Chemistry, Medicine
  • The Journal of pharmacology and experimental therapeutics
The pharmacological effects of N-[4-(2-bromoethylmethylamino)-2-butynyl]-2-pyrrolidone (BR 401) were compared in the mouse with those of N-[4-(2-chloroethylmethylamino)-2-butynl]-2-pyrrolidone (BM 123) and oxotremorine. BR 401 was more toxic than oxotremorine and BM 123 when administered i.v. (LD50, 0.7 mumol kg-1), but less toxic than oxotremorine when given i.p. (LD50, 39 mumol kg-1). Atropine and methylatropine (10 mumol kg-1 i.p.) increased the LD50 value of BR 401, given i.v., 75- to 100… 
4 Citations
Central oxotremorine antagonist properties of pirenzepine.
TLDR
It is suggested that pirenzepine interacts with central muscarinic receptors when administered systemically without producing marked behavioral effects of its own, and may be a useful tool in further investigations of the relevance of M1 receptors to behavioral function.
Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice.
  • J. Gomeza, H. Shannon, +6 authors J. Wess
  • Biology, Medicine
    Proceedings of the National Academy of Sciences of the United States of America
  • 1999
TLDR
The M2 muscarinic receptor subtype, besides its well documented involvement in the regulation of heart rate, plays a key role in mediating muscaric receptor-dependent movement and temperature control as well as antinociceptive responses, three of the most prominent central muscarinate effects.
Structural Determinants of Muscarinic Agonist Activity
Traditionally, structure-activity relationships (SAR) among muscarinic cholinergic agonists have been derived from dose-effect studies on isolated tissues or in whole animals (Barlow, 1964). In